Impel Pharmaceuticals Inc logo

Impel Pharmaceuticals Inc Share Price (NASDAQ: IMPL)

▲

-0.04

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 20 Dec 2023

Check the interactive Impel Pharmaceuticals Inc Stock chart to analyse performance

Impel Pharmaceuticals Inc Key Stats

Check Impel Pharmaceuticals Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.04
Open
$0.045
Market Capitalization
$1.3M
Today's Volume
$720.0K
Revenue TTM
$21.0M
EBITDA
$-69.0M
Earnings Per Share (EPS)
$-3.12
Dividend Yield
0.0%
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-2546.09%

Global Institutional Holdings in Impel Pharmaceuticals Inc

  • Name

    Holdings %

  • Kohlberg Kravis Roberts & Co LP

    17.31%

  • NVP Associates LLC

    12.88%

  • Vivo Capital, LLC

    12.07%

  • 5AM Venture Management, LLC

    12.07%

  • venBio Partners LLC

    11.55%

  • Vanguard Group Inc

    2.11%

Analyst Recommendation on Impel Pharmaceuticals Inc Stock

Rating
Trend

Buy

    75%Buy

    25%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Impel Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

About Impel Pharmaceuticals Inc

Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. Impel Pharmaceuticals Inc. was formerly known as Impel NeuroPharma, Inc. and changed its name to Impel Pharmaceuticals Inc. in April 2022. The company was incorporated in 2008 and is headquartered in Seattle, Washington.
Organization
Impel Pharmaceuticals Inc
Employees
160
CEO
Mr. Adrian Adams
Industry
Miscellaneous

Important FAQs about investing in IMPL Stock from India :

What is Impel Pharmaceuticals Inc share price today?

Impel Pharmaceuticals Inc share price today is as on at the close of the market. Impel Pharmaceuticals Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Impel Pharmaceuticals Inc share?

Impel Pharmaceuticals Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Impel Pharmaceuticals Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Impel Pharmaceuticals Inc Stock (IMPL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Impel Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Impel Pharmaceuticals Inc Shares .

What is the minimum amount required to buy Impel Pharmaceuticals Inc Stock (IMPL) from India?

Indian investors can start investing in Impel Pharmaceuticals Inc (IMPL) shares with as little as ₹87.7613 or $1 (as of September 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹877.61 in Impel Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025). Learn more about fractional shares .

What are the returns that Impel Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Impel Pharmaceuticals Inc stock has given 0.0% share price returns and 19.34% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?